Abbonarsi

Home-based exercise program for people with residual disability following hospitalization for COVID-19: Randomized control trial - 27/03/24

Doi : 10.1016/j.rehab.2023.101815 
Mara Paneroni a, , Simonetta Scalvini b, Elisa Perger c, d, Elisabetta Zampogna e, Simone Govetto c, Federico Mattia Oliva e, Ambra Matrone b, Palmira Bernocchi b, Debora Rosa c, Michele Vitacca f
a Istituti Clinici Scientifici Maugeri IRCCS, Cardio-Respiratory Rehabilitation Unit of the Institute of Lumezzane, Brescia, Italy 
b Istituti Clinici Scientifici Maugeri IRCCS, Cardiac Rehabilitation and Continuity of Care Units of Institute of Lumezzane, Brescia, Italy 
c Istituto Auxologico Italiano, IRCCS, Sleep Disorders Center & Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Milan, Italy 
d University of Milano Bicocca, Department of Medicine and Surgery, Milan, Italy 
e Istituti Clinici Scientifici Maugeri IRCCS, Respiratory Rehabilitation Unit of the Institute of Tradate, Varese, Italy 
f Istituti Clinici Scientifici Maugeri IRCCS, Respiratory Rehabilitation Unit of the Institute of Lumezzane, Brescia, Italy 

Corresponding author at: Istituti Clinici Scientifici Maugeri IRCCS, Via G Mazzini,129, 25065 Lumezzane, Brescia, Italy.Istituti Clinici Scientifici Maugeri IRCCSVia G Mazzini,129LumezzaneBrescia25065Italy

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Highlights

For individuals with residual disability following COVID-19 a home-based exercise program can be feasible and safe.
A remotely-supported home-based exercise intervention is most effective for individuals in the worst physical condition.
An at-home exercise program should be a rehabilitative option for those recovering from COVID-19.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Background

The best exercise program for individuals with effort intolerance or hypoxia at rest and/or during exercise post-COVID-19 treatment who have already had in-hospital rehabilitation remains unknown.

Objective

We evaluated the efficacy of a home-based rehabilitation exercise program intervention that included teleconsultations with a specialist nurse.

Methods

This was a multicenter randomized controlled trial for individuals who had been diagnosed with, and treated for, COVID-19. Despite inpatient rehabilitation they still had effort intolerance; this was defined as being a) only able to walk <70 % of the predicted distance during the six-minute walking test (6MWT) and/or b) oxygen desaturation all day long/during effort. The primary outcome was effort tolerance, as evaluated by the 6MWT. Secondary outcomes were dyspnea, fatigue, spirometry, respiratory muscle evaluations, and oxygenation. The Intervention group performed 4 weeks of a self-directed exercise program with bi-weekly physiotherapist video calls; the Control group participated in physical activity howsoever they wished. Exercises were divided into 4 intensity levels according to disability and oxygen desaturation. The program progressively increased from low (walking, free-body exercise, sit-to-stand, and balance exercises) to high (speed walking with a pedometer, cycle ergometer, and strengthening exercises).

Results

We included 79 participants: 40 in the Intervention and 39 in the Control group. Mean (SD) age was 67.1 (10.3) years; 72 % (n = 57) were male. No intergroup differences in effort tolerance were found [Intervention 77.6 (75.4)m vs Control 49.5 (73.3)m (p = 0.109)]. Participants with 6MWT distance results < lower limit of normality values showed best improvements in mean (SD) effort tolerance: Intervention, 120.1 (75.8)m vs Control, 59.1 (75.6)m (p = 0.035). After 2 months, mean (SD) 6MWT distances in the 2 groups were similar: Intervention, 475.9 (82.4)m vs Control, 469.2 (118.9)m (p = 0.807).

Conclusions

In individuals with residual disability post-COVID-19 and after inpatient rehabilitation, a home-based exercise program with teleconsultation significantly improves effort tolerance but only for people who had severe effort intolerance at baseline.

Database registration

ClinicalTrials.gov number, NCT04821934

Il testo completo di questo articolo è disponibile in PDF.

Keywords : COVID-19, Exercise, Teleconsultation, Healthcare providers

Abbreviations : ATS, BMI, Borg CR10, CIRS, COPD, DLCO, EID, ERS, FSS, FiO2, FEV1, FVC, LLN, MCID, MEP, MIP, MCS, PCS, PCR, PaO2, PaCO2, PT, RCT, SF12, SPPB, 1MSTS, 6MWD, 6MWT


Mappa


© 2023  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 67 - N° 2

Articolo 101815- marzo 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • Editorial board
| Articolo seguente Articolo seguente
  • Beneficial carry-over effects of chronic at-home genital nerve stimulation on incontinence in individuals with spinal cord injury: A pragmatic trial
  • Shauh-Der Yeh, Nurida Khasanah, Kenneth J. Gustafson, Chi Sun, Mei-Lin Tsai, Bor-Shing Lin, Chun-Wei Wu, Chih-Wei Peng

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.